Neuroone Medical Technologies (NMTC) Non Operating Income (2012 - 2021)

Neuroone Medical Technologies (NMTC) posted Non Operating Income of $83387.0 for Q2 2021, up 4597.86% on a QoQ basis from $1775.0 in Q1 2021.

Neuroone Medical Technologies (NMTC) Non Operating Income (2012 - 2021) Analysis & Trends

Neuroone Medical Technologies' Non Operating Income history runs 5 years deep, the most recent figure standing at $83387.0 for Q2 2021.

Quarterly Non Operating Income changed N/A year-over-year to $83387.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $270162.0 (changed N/A YoY) and the FY2013 annual result came in at -$5461.0, down 2305.73% from the prior year.
Non Operating Income was $83387.0 for Q2 2021 at Neuroone Medical Technologies, up from $1775.0 in the prior quarter.
Across five years, Non Operating Income topped out at $185000.0 in Q4 2020 and bottomed at $1775.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Op. Inc. (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	62.00 Mn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-18.60 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Neuroone Medical Technologies	7.99 Mn	5.19 Mn	990,264.00	-

Download Data